-
1
-
-
10544233783
-
-
and references cited therein
-
Guzikowski A.P., Espitia S.A., Hawkinson J.E., Huettner J.E., Nogales D.F., Wodward R.M., Weber E., Keana C. J. Med. Chem. 39:1996;4643-4653. and references cited therein
-
(1996)
J. Med. Chem.
, vol.39
, pp. 4643-4653
-
-
Guzikowski, A.P.1
Espitia, S.A.2
Hawkinson, J.E.3
Huettner, J.E.4
Nogales, D.F.5
Wodward, R.M.6
Weber, E.7
Keana, C.8
-
2
-
-
0032499216
-
-
and references cited therein
-
Link A., Kunick C. J. Med. Chem. 41:1998;1299-1305. and references cited therein
-
(1998)
J. Med. Chem.
, vol.41
, pp. 1299-1305
-
-
Link, A.1
Kunick, C.2
-
3
-
-
18244408049
-
-
Andrés J.I., Alcázar J., Alonso J.M., Díaz A., Fernández J., Gil P., Iturrino L., Matesanz E., Meert T.F., Megens A., Sipido V.K. Bioorg. Med. Chem. Lett. 12:2002;243-248
-
(2002)
Bioorg. Med. Chem. Lett.
, vol.12
, pp. 243-248
-
-
Andrés, J.I.1
Alcázar, J.2
Alonso, J.M.3
Díaz, A.4
Fernández, J.5
Gil, P.6
Iturrino, L.7
Matesanz, E.8
Meert, T.F.9
Megens, A.10
Sipido, V.K.11
-
4
-
-
18244395895
-
-
Andrés J.I., Alcázar J., Alonso J.M., Diaz A., Fernández J., Gil P., Iturrino L., Matesanz E., Meert T.F., Megens A., Sipido V.K. Bioorg. Med. Chem. Lett. 12:2002;249-253
-
(2002)
Bioorg. Med. Chem. Lett.
, vol.12
, pp. 249-253
-
-
Andrés, J.I.1
Alcázar, J.2
Alonso, J.M.3
Diaz, A.4
Fernández, J.5
Gil, P.6
Iturrino, L.7
Matesanz, E.8
Meert, T.F.9
Megens, A.10
Sipido, V.K.11
-
6
-
-
0033843730
-
-
Mizuno A., Miya M., Kamei T., Shibata M., Tatsuoka T., Nakanishi K., Takiguchi C., Hidaka T., Yamaki A., Inomata N. Chem. Pharm. Bull. 48:2000;1129-1137
-
(2000)
Chem. Pharm. Bull.
, vol.48
, pp. 1129-1137
-
-
Mizuno, A.1
Miya, M.2
Kamei, T.3
Shibata, M.4
Tatsuoka, T.5
Nakanishi, K.6
Takiguchi, C.7
Hidaka, T.8
Yamaki, A.9
Inomata, N.10
-
7
-
-
2442659555
-
-
U.S. Patent No 875, 495, 2001;
-
(c) Mizuno, A.; Shibata, M.; Iwamori, T.; Shimamoto, T.; Nakanishi, K.; Inomata, N. U.S. Patent No 875, 495, 2001; Chem. Abstr. 2001, 135, 92553
-
(2001)
Chem. Abstr.
, vol.135
, pp. 92553
-
-
Mizuno, A.1
Shibata, M.2
Iwamori, T.3
Shimamoto, T.4
Nakanishi, K.5
Inomata, N.6
-
12
-
-
0034604563
-
-
García Ruano J.L., Carreño M.C., Toledo M.A., Aguirre J.M., Aranda M.T. Angew. Chem., Int. Ed. 39:2000;2736-2737
-
(2000)
Angew. Chem., Int. Ed.
, vol.39
, pp. 2736-2737
-
-
García Ruano, J.L.1
Carreño, M.C.2
Toledo, M.A.3
Aguirre, J.M.4
Aranda, M.T.5
-
18
-
-
0042009346
-
-
García Ruano J.L., Fraile A., González G., Martín M.R., Clemente F.R., Gordillo R. J. Org. Chem. 68:2003;6522-6534
-
(2003)
J. Org. Chem.
, vol.68
, pp. 6522-6534
-
-
García Ruano, J.L.1
Fraile, A.2
González, G.3
Martín, M.R.4
Clemente, F.R.5
Gordillo, R.6
-
25
-
-
0028344826
-
-
and references cited therein
-
Rispens M.T., Keller E., de Lange B., Zijlstra W.J., Feringa B.L. Tetrahedron Asymmetry. 4:1994;607-624. and references cited therein
-
(1994)
Tetrahedron Asymmetry
, vol.4
, pp. 607-624
-
-
Rispens, M.T.1
Keller, E.2
De Lange, B.3
Zijlstra, W.J.4
Feringa, B.L.5
-
26
-
-
2442657039
-
-
note
-
3a (Scheme 2), is related to the face of the dipolarophile, which is attacked by the dipole, using as a reference the spatial arrangement of the ethoxy group. The endo- or exo-terms, indicative of the cis- or trans-arrangement exhibited by furanone and azepine moieties at the isoxazolidine ring, are related to the endo- and exo-addition modes of the dipole, using the ester group at the furanone ring as a reference
-
-
-
-
29
-
-
2442683378
-
-
note
-
Crystallographic data (excluding structure factors) for anti-3a-endo have been deposited with the Cambridge Crystallographic Data Centre as suplementary publication number CCDC 190809. Copies of the data can be obtained, free of charge, on application to CCDC, 12 Union Road, Cambridge CB2 1EZ, UK [fax: +44(0)-1223-366033 or e-mail: deposit@ccdc.cam.ac.uk]
-
-
-
-
32
-
-
0035208520
-
-
Kubáň J., Kolarovič A., Fišera L., Jäger V., Humpa O., Prónayová N. Synlett. 2001;1866-1868
-
(2001)
Synlett
, pp. 1866-1868
-
-
Kubáň, J.1
Kolarovič, A.2
Fišera, L.3
Jäger, V.4
Humpa, O.5
Prónayová, N.6
-
33
-
-
2442655803
-
-
note
-
The in vitro screening of the compounds was performed at Johnson & Johnson Pharmaceutical Research & Development, Division of Janssen Pharmaceutica N.V., Turnhoutsweg 30, B2340 Beerse, Belgium. The authors would like to acknowledge support from this company
-
-
-
|